Suggestions to Chinese manufacturers of pharmaceutical packing materials under the policy of associated evaluationQIAN Jing-yi, LIU Bo-yan, YU Zheng972-977
Patent application in pharmaceutical crystal field and the examination of its inventive stepLI Xue-ying, WANG Jing, ZHU Wei978-982
Data extrapolation strategy and general consideration for the products approved for pediatric use overseaGENG Ying, SUN Yan-zhe, LI Qiang, ZHANG Hao, ZHAO De-heng, YANG Zhi-min983-986
Analysis of FDA assessment consideration on cannabidiol indicated for refractory epilepsyGUAN Hong-feng, LIU Li-hua, DA Hong-yuan, ZHANG Yong-wen987-992
The determination of rituximab and its biosimilar in human serum by ELISALI Li, CHEN Jie, LI Kun, JIA Zhi-jun, ZOU Jia, CHEN Fang, DONG Li-hou, OU Lun, DONG Jing, SONG Hai-feng993-1000
Progress in the application of PD-1/PD-L1 inhibitors in neoadjuvant chemotherapyQIU Xue-jia, ZHANG Yue, LIAN Yu-fei, LI Xiao-ming, CAO Ge-xi, DUAN Bao-jing1007-1011
The effects of butylphthalide on patients with progressive infarction and the serum IL-6 and protein expression of S100BYANG Jing, LI Feng, SHI Chang-qing1018-1022